NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $169.63 -2.72 (-1.58%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends About VanEck Biotech ETF (NASDAQ:BBH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VanEck Biotech ETF alerts:Sign Up Key Stats Today's Range$169.61▼$170.8550-Day Range$170.87▼$181.8452-Week Range$142.51▼$183.64Volume3,358 shsAverage Volume6,680 shsMarket Capitalization$432.56 millionAssets Under Management$434.45 millionDividend Yield0.42%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF OverviewThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More… We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.55%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.53%Total Expense0.35%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%Net Expense0.35%0.61%0.61%0.56%0.59% Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBH ETF News HeadlinesAre Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comEmphasize Consistency To Navigate VolatilitySeptember 7, 2024 | seekingalpha.comMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 31, 2024 | Paradigm Press (Ad)VanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummaryAugust 29, 2024 | benzinga.com3 Biotech ETFs for a Diversified PortfolioAugust 15, 2024 | stocknews.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 29, 2024 | benzinga.comSee More Headlines BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH stock has increased by 2.9% and is now trading at $170.03. View the best growth stocks for 2024 here. Who are VanEck Biotech ETF's major shareholders? Top institutional shareholders of VanEck Biotech ETF include International Assets Investment Management LLC (44.76%), Pacific Sun Financial Corp (0.22%) and Creative Planning (0.07%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ). Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$434.45 million Average Daily Volume$3,513.60 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest1,100 shs Miscellaneous Outstanding Shares2,550,000Beta0.85 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Top 10 BBH HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 16.76%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 10.28%Gilead Sciences (NASDAQ:GILD)Holding Weight: 9.77%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.85%IQVIA (NYSE:IQV)Holding Weight: 4.97%argenx (NASDAQ:ARGX)Holding Weight: 4.83%ICON Public (NASDAQ:ICLR)Holding Weight: 4.47%Illumina (NASDAQ:ILMN)Holding Weight: 4.12%Biogen (NASDAQ:BIIB)Holding Weight: 4.10%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.77%Full Holdings DetailsBBH Sector ExposureBBH Industry Exposure This page (NASDAQ:BBH) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.